Caplin Point Laboratories has informed that the board of directors of the company at its meeting held on November 21, 2011, inter alia, has recommended a final dividend of Re 1.50 per share (15%) on the equity capital for the year ended June 30, 2011.
The above information is part of the company’s filing submitted to the BSE.